| pubmed-article:15359893 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15359893 | lifeskim:mentions | umls-concept:C0025289 | lld:lifeskim |
| pubmed-article:15359893 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:15359893 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:15359893 | lifeskim:mentions | umls-concept:C0121772 | lld:lifeskim |
| pubmed-article:15359893 | lifeskim:mentions | umls-concept:C0007561 | lld:lifeskim |
| pubmed-article:15359893 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:15359893 | pubmed:dateCreated | 2004-9-13 | lld:pubmed |
| pubmed-article:15359893 | pubmed:abstractText | Haemophilus influenzae type b (Hib) is the most frequent pathogen of bacterial meningitis in Japanese children. The prevalence of beta-lactamase-negative ampicillin-resistant (BLNAR) Hib strain has been increasing in recent years. Furthermore, antibiotic activities of cefotaxime (CTX) and ceftriaxone (CTRX) have decreased against some of those BLNAR strains. We report a case of one-year-old boy who suffered from meningitis caused by BLNAR Hib. The MICs of CTX and CTRX for the strain isolated from cerebrospinal fluid was 1.0 and 0.5 microg/ml, respectively. The patient was administered high-dose CTRX (150 mg/kg/day) and recovered completely without any sequela. The high-dose CTRX administration may be a considerable choice of the treatment of BLNAR meningitis. | lld:pubmed |
| pubmed-article:15359893 | pubmed:language | jpn | lld:pubmed |
| pubmed-article:15359893 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15359893 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15359893 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15359893 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15359893 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15359893 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15359893 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:15359893 | pubmed:issn | 0387-5911 | lld:pubmed |
| pubmed-article:15359893 | pubmed:author | pubmed-author:NakamuraAkira... | lld:pubmed |
| pubmed-article:15359893 | pubmed:author | pubmed-author:KohnoYoichiY | lld:pubmed |
| pubmed-article:15359893 | pubmed:author | pubmed-author:HoshinoTadash... | lld:pubmed |
| pubmed-article:15359893 | pubmed:author | pubmed-author:IshiwadaNaruh... | lld:pubmed |
| pubmed-article:15359893 | pubmed:author | pubmed-author:SudoFusayoF | lld:pubmed |
| pubmed-article:15359893 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15359893 | pubmed:volume | 78 | lld:pubmed |
| pubmed-article:15359893 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15359893 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15359893 | pubmed:pagination | 604-8 | lld:pubmed |
| pubmed-article:15359893 | pubmed:dateRevised | 2008-12-16 | lld:pubmed |
| pubmed-article:15359893 | pubmed:meshHeading | pubmed-meshheading:15359893... | lld:pubmed |
| pubmed-article:15359893 | pubmed:meshHeading | pubmed-meshheading:15359893... | lld:pubmed |
| pubmed-article:15359893 | pubmed:meshHeading | pubmed-meshheading:15359893... | lld:pubmed |
| pubmed-article:15359893 | pubmed:meshHeading | pubmed-meshheading:15359893... | lld:pubmed |
| pubmed-article:15359893 | pubmed:meshHeading | pubmed-meshheading:15359893... | lld:pubmed |
| pubmed-article:15359893 | pubmed:meshHeading | pubmed-meshheading:15359893... | lld:pubmed |
| pubmed-article:15359893 | pubmed:meshHeading | pubmed-meshheading:15359893... | lld:pubmed |
| pubmed-article:15359893 | pubmed:meshHeading | pubmed-meshheading:15359893... | lld:pubmed |
| pubmed-article:15359893 | pubmed:meshHeading | pubmed-meshheading:15359893... | lld:pubmed |
| pubmed-article:15359893 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15359893 | pubmed:articleTitle | [Successful treatment of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae type b meningitis with high-dose ceftriaxone administration]. | lld:pubmed |
| pubmed-article:15359893 | pubmed:affiliation | Division of Infectious Diseases, Chiba Children's Hospital. | lld:pubmed |
| pubmed-article:15359893 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15359893 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:15359893 | pubmed:publicationType | Case Reports | lld:pubmed |
